
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
REP-1 CRISPR/Cas9 KO Plasmid (h) | sc-404025 | 20 µg | $397.00 | |||
REP-1 HDR Plasmid (h) | sc-404025-HDR | 20 µg | $445.00 |
CHM encodes Rab escort protein 1 (REP-1), a key component of the Rab geranylgeranylation machinery that enables prenylation, membrane association, and proper subcellular targeting of Rab GTPases. By facilitating Rab-dependent vesicle budding, trafficking, and fusion events, REP-1 supports endosomal sorting, lysosomal transport, and regulated secretion across multiple cell types. Disruption of CHM impairs Rab prenylation and downstream trafficking pathways, leading to cellular stress and altered organelle dynamics. Pathogenic variants in CHM are associated with X-linked choroideremia, making REP-1 a relevant node for studying vesicle transport defects and tissue-specific vulnerability.
REP-1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CHM gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the CHM locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, REP-1 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined CHM target site.
When co-transfected with REP-1 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the CHM locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.